Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × lutetium Lu 177 dotatate × Other neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1 NET 1 Gastrointestinal 1 Endocrine 1

Conditions

Digestive System Neuroendocrine Tumor G1 1

Interventions

peginterferon alfa-2b 1 lutetium Lu 177 dotatate 1 Zidovudine 1 Valproic Acid 1 Magnetic Resonance Spectroscopy 1 Interferon alpha-2 1 64Cu-DOTATATE 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06016855 2025-12-17

Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors

Vanderbilt-Ingram Cancer Center

Phase 4 Recruiting

EndocrineGastrointestinalNETOther neoplasm

Digestive System Neuroendocrine Tumor G1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡